Is Cellebrite (CLBT) Poised to Re-Accelerate in 2026?
Voss Capital, LLC, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cellebrite Di Ltd. (CLBT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Voss Capital Travis Cocke | 5,150,000 | $82,400,000 | +34% | 5.68% |
| 2. | Pertento Partners Ian Trundle | 2,945,641 | $47,130,256 | +12% | 4.22% |
| 3. | Renaissance Technologies Jim Simons | 2,686,339 | $42,981,424 | +3% | 0.06% |
| 4. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 2,121,534 | $33,945,000 | +7% | 10.1% |
| 5. | Millennium Management Israel Englander | 2,000,829 | $32,013,264 | +282% | 0.02% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,861,007 | $221,776,112 | 93.81% | |
| 2. | 9,000,000 | $144,000,000 | 100% | |
| 3. | 6,161,302 | $98,580,825 | 0.01% | |
| 4. | 4,652,578 | $74,441,248 | 0% | |
| 5. | 3,505,552 | $56,088,832 | 0.01% |
News See All
Craig-Hallum Reiterates a Buy Rating on Cellebrite DI Ltd. (CLBT)
Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the best stocks under $20 to buy for the long term. On August 19, Craig-Hallum analyst Jeff Van Rhee maintained a Buy rating on Cellebrite DI Ltd.
10 Best Stocks Under $20 to Buy for the Long Term
On August 22, Manpreet Gill of Standard Chartered Wealth Management appeared on CNBC, stating that he sees a cut in the Federal Reserve’s upcoming September meeting and that it’s time to “lock in...
Cellebrite (CLBT) Fell Due to Below-Expected Outlook, but Core Trends Persist
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Cellebrite (CLBT) Fell on Investors' Worry that US Federal Budget Uncertainty Could Delay Purchases
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here.
Cellebrite (CLBT) Cheers on 3rd Day After Swing to Profit
In its updated report, Cellebrite DI Ltd. (NASDAQ:CLBT) climbed to a net income of $19.48 million from a $23.8 million net loss in the same period last year.
Cellebrite DI Ltd. (NASDAQ:CLBT) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Cellebrite Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] I would now like to turn call over to your first speaker today, Mr. Andrew Kramer.
Cellebrite DI Ltd. (CLBT): A Bull Case Theory
We came across a bullish thesis on Cellebrite DI Ltd. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on CLBT.
US Department of Justice to Sponsor Cellebrite DI (CLBT) for FedRAMP High Authorization for its Government Cloud platform
Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the Best Tech Stocks to Buy Under $20. On July 23, Cellebrite DI Ltd.
10 Best Tech Stocks to Buy Under $20
On July 29, Stuart Kaiser, Citi Head of Equity Trading Strategy, joined CNBC for an interview to discuss the risks and driving factors for the market.
Hedge Fund Resource Center Billionaire Hedge Funds
